Talc in Treating Patients With Malignant Pleural Effusion
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Talc may relieve malignant pleural effusion. It is not yet known whether wet talc
is more effective than dry talc in treating patients with malignant pleural effusion.
PURPOSE: Randomized phase III trial to compare the effectiveness of wet talc with dry talc in
treating patients with malignant pleural effusion.
Phase:
Phase 3
Details
Lead Sponsor:
Alliance for Clinical Trials in Oncology
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI) North Central Cancer Treatment Group Radiation Therapy Oncology Group